SELECT PUBLICATIONS

Adler WM et al. CEX (celecoxib, oxaliplatin, capecitabine) and XRT: A novel neoadjuvant approach for locally advanced rectal cancer. Proc ASCO 2005;Abstract 3744.

Bosset JF et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results — EORTC 22921. J Clin Oncol 2005;23(24):5620-7. Abstract

Bosset JF et al. Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial. Proc ASCO 2005;Abstract 3505.

Bosset JF et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004;40(2):219-24. Abstract

Cohen SM, Neugut AI. Adjuvant therapy for rectal cancer in the elderly. Drugs Aging 2004;21(7):437-51. Abstract

Corvo R et al. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: Rationale, preliminary results and perspectives. Tumori 2003;89(4):361-7. Abstract

Das P et al. Clinical and pathologic predictors of locoregional recurrence (LR), distant metastasis (DM) and overall survival (OS) in patients treated with chemoradiation and mesorectal excision for locally advanced rectal cancer. Proc ASCO 2005;Abstract 3597.

De Paoli A et al. Neoadjuvant therapy of rectal cancer: New treatment perspectives. Tumori 2004;90(4):373-8. Abstract

Fernandez-Martos C et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years’ follow-up. J Clin Oncol 2004;22(15):3016-22. Abstract

Folkesson J et al. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23(24):5644-50. Abstract

Gambacorta MA et al. Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study. Int J Radiat Oncol Biol Phys 2004;60(1):130- 8. Abstract

Gerard J et al. Preoperative (preop) radiotherapy (RT) + 5 FU/folinic acid (FA) in T3-4 rectal cancers: Results of the FFCD 9203 randomized trial. Proc ASCO 2005;Abstract 3504.

Gerard JP et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The lyon R96-02 randomized trial. J Clin Oncol 2004;22(12):2404-9. Abstract

Glimelius B et al. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003;42(5-6):476-92. Abstract

Glynne-Jones R et al. Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC). Proc ASCO 2005;Abstract 3527.

Gunderson LL et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 2004;22(10):1785-96. Abstract

Kim CS et al. Tumor size as a predictor of pathologic complete response (pCR) and survival in a prospective trial of chemoradiation for locally advanced rectal cancer. Proc ASCO 2005;Abstract 3672.

Klaassen RA et al. Treatment of locally advanced rectal cancer. Surg Oncol 2004;13(2-3):137-47. Abstract

Klautke G et al. Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 2005;92(7):1215-20. Abstract

Lygidakis NJ, Safioleas M. Multimodality approach towards advanced rectal carcinoma. Its efficacy and safety. Hepatogastroenterology 2005;52(62):385-90. Abstract

Mawdsley S, Glynne-Jones R. The importance of pathological downstaging and the circumferential margin in rectal carcinomas treated with neoadjuvant chemoradiation. Proc ASCO 2005;Abstract 3642.

Minsky BD. Combined modality therapy of resectable rectal cancer: Current approaches. Tech Coloproctol 2004;8(2):67-76. Abstract

Ngan SY et al. Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801). Dis Colon Rectum 2005;48(7):1389-96. Abstract

Pacelli F et al. Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer. Dis Colon Rectum 2004;47(2):170-9. Abstract

Rodel C, Sauer R. Radiotherapy and concurrent radiochemotherapy for rectal cancer. Surg Oncol 2004;13(2-3):93-101. Abstract

Sauer R et al. Prognostic factors after neoadjuvant radiochemotherapy for rectal cancer: Update of the CAO/ARO/AIO-94 Phase III study. Proc ASCO 2005;Abstract 3503.

Sauer R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731-40. Abstract

Tsavaris N et al. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer. Oncol Rep 2004;12(4):927-32. Abstract

Willett CG et al. Direct evidence that the VEGFspecific antibody bevacizumab has antivascular effects in human rectal cancer. Nature Med 2004;10(2):145-7. Abstract

Wu WX et al. Laparoscopic versus conventional open resection of rectal carcinoma: A clinical comparative study. World J Gastroenterol 2004;10(8):1167-70. Abstract